Skip to content
Outcomes4Me Announces Investments from Labcorp and Comcast’s Forecast Labs
Learn more >>
Patient Resources
Ask the Expert Webinars
Cancer Conference Highlights
Treatment Options
Signs and Symptoms
Living with Breast Cancer
Cancer and Wellness
Health Equity
Research Updates
Cancer and Relationships
Patient Stories
Breast Cancer Resources
What We Do
For Patients
For Oncology Care Providers
For Life Sciences
Company
Our Story
Management
Thought Leadership
In the News
Careers
Contact
Sign Up
Get Our App
Menu
Patient Resources
Ask the Expert Webinars
Cancer Conference Highlights
Treatment Options
Signs and Symptoms
Living with Breast Cancer
Cancer and Wellness
Health Equity
Research Updates
Cancer and Relationships
Patient Stories
Breast Cancer Resources
What We Do
For Patients
For Oncology Care Providers
For Life Sciences
Company
Our Story
Management
Thought Leadership
In the News
Careers
Contact
Sign Up
Get Our App
Get Treatment Options
/
January 31, 2023
Search
Search
for-life-sciences
,
for-patients
,
Research Updates
,
thought leadership
,
Treatment Options
Newsflash: First Oral SERD Orserdu (elacestrant) FDA-Approved
If you were diagnosed with ER-positive, HER2-negative metastatic breast cancer and are now wondering if...
January 31, 2023
